These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 38223089)
1. Prognostic value of Geng H; Lian K; Zhang W Quant Imaging Med Surg; 2024 Jan; 14(1):325-334. PubMed ID: 38223089 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of metabolic tumour volume on baseline Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463 [TBL] [Abstract][Full Text] [Related]
3. [ Xu HQ; Song LJ; Ding CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Values of Baseline Zhou Y; Zhang X; Qin H; Zhao Z; Li J; Zhang B; Sang S; Wu Y; Deng S Biomed Res Int; 2020; 2020():9746716. PubMed ID: 32185229 [TBL] [Abstract][Full Text] [Related]
5. Metabolic tumour area: a novel prognostic indicator based on Cui S; Xin W; Wang F; Shao X; Shao X; Niu R; Zhang F; Shi Y; Liu B; Gu W; Wang Y BMC Cancer; 2024 Jul; 24(1):895. PubMed ID: 39054508 [TBL] [Abstract][Full Text] [Related]
6. [ Gui J; Li M; Xu J; Zhang X; Mei H; Lan X Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2308-2319. PubMed ID: 38467921 [TBL] [Abstract][Full Text] [Related]
7. Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment. Jin H; Jin M; Lim CH; Choi JY; Kim SJ; Lee KH Front Oncol; 2023; 13():1186311. PubMed ID: 37384292 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic Value of Su JM; Zheng QZ; Huang WR; Deng J; Wu J; Lu HQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1181-1186. PubMed ID: 34362500 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of baseline Zhou Y; Hong Z; Zhou M; Sang S; Zhang B; Li J; Li Q; Wu Y; Deng S J Med Imaging Radiat Oncol; 2020 Feb; 64(1):87-95. PubMed ID: 31880103 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
12. A better prediction of progression-free survival in diffuse large B-cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV Zhang YY; Song L; Zhao MX; Hu K Cancer Med; 2019 Sep; 8(11):5137-5147. PubMed ID: 31343111 [TBL] [Abstract][Full Text] [Related]
13. A preliminary investigation of the relationship between Hu L; Luo N; Li L; Qiu D; Hu X Front Oncol; 2023; 13():1171048. PubMed ID: 37397396 [TBL] [Abstract][Full Text] [Related]
14. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma. Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054 [TBL] [Abstract][Full Text] [Related]
15. Value of Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis. Guo B; Tan X; Ke Q; Cen H PLoS One; 2019; 14(1):e0210224. PubMed ID: 30625203 [TBL] [Abstract][Full Text] [Related]
17. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma. Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082 [TBL] [Abstract][Full Text] [Related]
18. Metabolic tumor burden on baseline Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma. Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875 [TBL] [Abstract][Full Text] [Related]
20. Will Baseline Total Lesion Glycolysis Play a Role in Improving the Prognostic Value of the NCCN-IPI in Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated With the R-CHOP Regimen? Jiang C; Ding C; Xu J; Teng Y; Chen J; Wang Z; Zhou Z Clin Nucl Med; 2021 Jan; 46(1):1-7. PubMed ID: 33181743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]